Condition: Parkinson's Disease · Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
This program aims to understand the role of the subthalamic nucleus in the control of the movement in healthy humans and patients with Parkinson's disease, how the STN dysfunction contributes to akinesia and how the STN stimulation improves motor signs in PD patients .
This description comes directly from the study's public registry record.
Marie-Laure Welter, MD, PhD · marielaure.welter@icm-institute.org
Carine Karachi, MD, PhD · carine.karachi@gmail.com
Always discuss trial participation with your own doctor first.
| Groupe Hospitalier Pitie-Salpêtrière | Paris, PARIS, France | Recruiting |
| CIC-GHPS | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01682668